Status:
COMPLETED
Effect of Electroacupuncture in Patients With Irritable Bowel Syndrome
Lead Sponsor:
Chinese University of Hong Kong
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Irritable bowel syndrome (IBS) is the most common digestive disorder that affects more than 5% of population in Hong Kong. However, there is no effective treatment of IBS using Western Medicine. Acupu...
Detailed Description
All patients will be evaluated for study eligibility at visit 1 (baseline). Baseline assessment includes the following items: 1. Global symptom assessment: Based on Rome III Working Group recommendat...
Eligibility Criteria
Inclusion
- Irritable bowel syndrome of diarrhea type as defined by Rome III criteria
- Age 18-65 years
- Normal colonic evaluation within 12 months (with either colonoscopy or barium study)
Exclusion
- IBS-constipation, mixed or unsubtyped
- Pregnancy
- Medical history of organic colonic bowel disease
- History of sensitivity to acupuncture
- Psychiatric or additive disorder
- Patients who have received acupuncture in the past 6 months
- Concomitant medications including anti-diarrhea agent, anti-depressant, narcotic analgesic and anti-cholinergic
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00900965
Start Date
April 1 2008
End Date
December 1 2008
Last Update
July 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong, Prince of Wales Hospital
Shatin, Hong Kong, China